The blood test designed to predict the onset of chronic kidney disease up to four years before symptoms appear.
Clinically proven
2,100+ collection sites
Actionable results
The current standard of care for predicting diabetes related Chronic Kidney Disease is not good enough.
The current standard of care testing for Chronic Kidney Disease (CKD) includes a blood test (eGFR) and a urine test (uACR). These tests only provide evidence of kidney damage that has already occurred. This test is different. This test identifies kidneys under stress which will progress to CKD if not actively managed. This test correctly identified 86% of low risk patients who progressed to CKD, up to four years before traditional tests like eGFR or ACR showed any signs of damage1,2.
How it works

Get Medical Authorisation
Download the referral form to take to your preferred health care provider to get medical authorisation.

Provide your sample
Attend one of our participating collection centers. Bring your signed test requisition form with you. No appointment is necessary.

Get answers in days
Your health care provider will get an email when your results are ready (within 2 to 4 weeks). They may schedule a follow-up consult with you.

Proactively changing renal healthcare
Safeguard your kidney health
The science behind our test
4 years
Predicts your risk of kidney disease up to 4 years before symptoms appear.
13.5x
People with a ‘high risk’ result by our test are 13.5x more likely to develop kidney disease than a ‘low risk’ result.
86%
Proven to predict kidney disease risk with 86% accuracy.
The cost of the status quo
Acting now means investing in your health now and preventing potentially large, future expenses and significant impacts on your life.
Cost (per year)
Early detection & management:
$200-$300 for tests and early medications
Dialysis (Late stage kidney disease):
> $85,000+ (public) / $100,000+ (private)
Quality of life
Early detection & management:
Maintain a normal daily lifestyle
Dialysis (Late stage kidney disease):
Multiple hospital visits a week, dietary restrictions and fatigue
Healthcare burden
Early detection & management:
Low
Dialysis (Late stage kidney disease):
Very high
Outcome
Early detection & management:
Kidney function preserved
Dialysis (Late stage kidney disease):
Lifelong dialysis treatment or even transplant
Developed by Proteomics International
Its founder, Dr Richard Lipscombe, is a global leader in the field of proteomics; the study of proteins to better understand disease. With over 25 years of experience in both academic research and biotech innovation, his expertise in mass spectrometry has helped transform how we detect disease before symptoms appear.
Chronic kidney disease is a major public health challenge, and our test offers a highly innovative, accurate, and accessible way to identify those most at risk. By enabling proactive management, we aim to reduce the personal and financial costs associated with this life-threatening condition.
Dr Richard Lipscombe
Founder, Proteomics International


Our test is a proactive breakthrough blood test that identifies CKD risk before kidney damage begins.
Measures
Our test:
Your individualised future risk.
Standard test:
Your current kidney damage.
Timing
Our test:
Up to 4 years before kidney damage occurs.
Standard test:
After damage has already happened.
Interpretation
Our test:
Accurately identifies patients with functioning kidneys today but low to high risk of CKD within 4 years.
Standard test:
Inaccurate, especially in early stages.
Action
Our test:
Work with your physician to start kidney health management plan early. (extending years of life)
Standard test:
Try to slow the damage, and reduce the risk of lifelong dialysis or even transplant.
Are you a medical professional?
The blood test designed to predict the onset of chronic kidney disease up to four years before symptoms appear.
What is the chronic kidney disease test?
1 in 3 people with diabetes will develop kidney disease, which can lead to dialysis or a transplant 1,2.
Our test can predict your risk of kidney disease years for up to 4 years before symptoms appear. Early detection helps you and your doctor take action to delay or prevent its progression.
Although your doctor may have you taking regular kidney function tests such as eGFR or ACR, these tests do not predict the onset of kidney disease. Studies show the test is 86% accurate in predicting kidney disease up to 4 years in advance. Patients identified as "high risk" by the test are 13.5 times more likely to develop kidney disease3,4.
The test also helps doctors choose treatments. Patients at high risk may benefit most from kidney-protecting drugs, and doctors may use these results to adjust medications and monitor patients more closely5,6.
Who should take the test?
The test is suitable for adults who have been diagnosed with diabetes (type 2) by a health professional and have an eGFR of greater than 30ml/min/1.73m2.
What does the test measure?
The test works by measuring protein biomarkers in your blood that are linked with kidney disease.
A scientifically proven algorithm combines these results with data about your age and eGFR (a kidney function measure). It then calculates how likely it is you will develop kidney disease in the next 4 years.
When should I do the test?
If you’re eligible, it’s never too early to take the test. In fact, early detection of kidney disease may help your doctor slow or stop disease progression8. Knowing your risk helps you and your doctor develop a plan to keep your kidneys healthy for as long as possible.
What to expect with your results?
The chronic kidney disease test algorithm works out a score indicating how likely it is your kidney function will decline over the next 4 years. It uses a traffic light system to classify your risk.
• Green = low risk of kidney disease
• Amber = moderate risk of kidney disease
• Red = high risk of kidney disease
What happens after I get my result?
Your test results will be sent to your referring doctor. They may schedule an appointment to explain your results, answer your questions, and discuss next steps. With this test report, your doctor can work with you to create a treatment plan to help keep your kidneys healthy for as long as possible.
Depending on the results, your doctor might suggest: lifestyle changes such as healthy eating, managing your weight and quitting smoking more frequent monitoring avoiding medicines that can damage the kidneys prescribing medication designed to protect kidney function.
What is type 2 diabetes?
Type 2 diabetes is a condition that affects your body’s ability to make and use insulin, a hormone that helps to regulate your blood sugar levels. This leads to a build-up of glucose (a type of sugar) in your bloodstream, leading to high blood sugar levels. Unless type 2 diabetes is well managed, the high blood sugar levels can lead to complications including heart disease, kidney damage, nerve damage, and vision problems.
What is diabetic kidney disease?
Diabetic kidney disease (DKD), also known as diabetic nephropathy, is a complication of diabetes. It affects the kidneys' ability to filter waste materials from the blood. Over time, high blood sugar levels can damage the small blood vessels and structures in the kidneys, leading to reduced kidney function. In severe cases, this can result in kidney failure.
What is chronic kidney disease?
Chronic Kidney Disease (CKD) is a long-term condition where the kidneys gradually lose their ability to filter waste and excess fluid from the blood, often without noticeable symptoms in the early stages. If left unmanaged, CKD can lead to serious complications such as high blood pressure, anaemia, heart disease, and eventually kidney failure. It’s commonly caused by conditions like diabetes and high blood pressure, and is diagnosed through blood and urine tests. While CKD can’t always be reversed, early detection and lifestyle changes can help slow its progression and reduce the risk of complications.
What is eGFR?
Estimated glomerular filtration rate (eGFR) is a measure of how well your kidneys are filtering waste from your blood. It is calculated based on your age, gender, and the level of creatinine in the blood. eGFR results help healthcare providers assess kidney function.
Am I eligible for the test?
To be eligible, you must:
- Be 18 years of age or older
- Have a diagnosis of type 2 diabetes from a healthcare professional
- Have an eGFR greater than 30ml/min/1.73m2
How do I take the test?
Follow these simple steps to take the chronic kidney disease test.
1. Download the test referral form.
2. Take the referral form to your health care provider to discuss your eligibility.
3. Take the signed referral form to a participating collection centre and have your blood sample taken.
4. Wait for your doctor to contact you.
How much does it cost and can I get a Medicare rebate?
The chronic kidney disease test costs $295, with a current introductory price of $125. As the test is new, it is not yet covered by Medicare.
How long until I get my results?
2 to 4 weeks depending on where you are located.
Do I need a doctors referral?
Yes. You can get a referral from your preferred health care provider.
How often should I take the test?
This depends on your results. Current clinical recommendations suggest the following:
-
Low Risk - every 4 years
-
Moderate Risk - every 2 years
- High Risk - as determined by your doctor
Are my results and personal details kept private?
We know health information is sensitive and we take your privacy very seriously. Your test results are private and confidential.
Our laboratory system stores your personal information on highly secure, encrypted servers. This information is never shared with third parties without your explicit approval.
References
- AIHW. Chronic kidney disease: Australian facts. Last updated: 17 Jun 2024. Available at https://www.aihw.gov.au/reports/chronic-kidney-disease/chronic-kidney-disease/contents/risk-factors/diabetes. Accessed 4 Dec 2024.
- de Boer, Ian H et al. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes care vol. 45,12 (2022): 3075-3090. doi:10.2337/dci22-0027.
- Peters KE, et al. Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase II. J Diab Comp. 2019.
- Peters KE, et al. Diabetic kidney disease test Predicts Renal Function Decline in Type 2 Diabetes in the Cana. Cardiovascular Assessment Study (CANVAS). Journal of Clinical Medicine. 2020.
- Peters KE, et al. Cana. Attenuates Diabetic kidney disease test Diabetic Kidney Disease Risk Prediction Scores, Journal of Clinical Medicine. 2023.
- Fusfeld L, et al. Evaluation of the Clinical Utility of Diabetic kidney disease test In-Vitro Test in Predicting Diabetic Kidney Disease and Rapid Renal Decline. PLOS ONE. 2022.
- Peters KE,et al. PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes, Diagnostics. 2025.
- UpToDate. Early detection of chronic kidney disease. Available at https://www.uptodate.com/contents/early-detection-of-chronic-kidney-disease. Accessed 5 Dec 2024.
Find a blood collection location
Available at any Healius pathology centre location in Australia.
Take your next step with confidence
Know your risk and your doctor can help you make your next healthcare decision with confidence.

Follow us:
6 Verdun Street, Nedlands WA, Australia 6009
Contact Us
Terms of Use


